We present estimates of the contraceptive prevalence rate (CPR), modern contraceptive prevalence rate (mCPR), demand satisfied, and the method of contraception used for both partnered and unpartnered women for 5-year age groups in 204 countries and territories between 1970 and 2019.
High prevalence of diabetes has been reported in the Americas, but no comprehensive analysis of diabetes burden and related factors for the region is available. We aimed to describe the burden of type 1 and type 2 diabetes and that of hyperglycaemia in the Americas from 1990 to 2019.
Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year.
We provide estimates of visual acuity loss and blindness in the US by county.
In view of the high and increasing prevalence of diabetes, we aimed to quantify the burden of type 2 diabetes attributable to PM2·5 originating from ambient and household air pollution.
We report US spending-effectiveness ratios, using comprehensive estimates of health care spending from the Disease Expenditure Project and DALYs from the Global Burden of Disease Study 2017.
Multiple surveys that were conducted to examine the sentiments concerning coronavirus disease 19 (Covid-19) vaccination have exposed new levels of volatility around vaccine hesitancy, particularly when the hesitancy is powered by digital media platforms.
We sought to report comprehensive trends in injury-related mortality and morbidity for adolescents aged 10–24 years during the past three decades.
Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties.
We measured life expectancy at birth, by sex and year, for subgroups of people reporting Hispanic, non-Hispanic Black, or non-Hispanic White race/ethnicity.
We used advances in meta-regression methods and estimates of vaccine efficacy by location to estimate incremental cost-effectiveness ratios (ICERs) for rotavirus vaccination in 195 countries.
We estimated the global, regional, and national prevalence of hepatitis B virus (HBV), as well as mortality and disability-adjusted life-years (DALYs) due to HBV, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
This analysis estimated life expectancy for five racial–ethnic groups, in 3,110 US counties over 20 years, to describe spatial–temporal variations in life expectancy and disparities between racial–ethnic groups.
This paper samples across a range of potential variant-level characteristics to provide global forecasts of infections, hospitalisations, and deaths in the face of high (but waning) levels of past immunity, and evaluates a range of interventions that may diminish the impact of future waves.
The objective of this study is to examine progress on implementing the Global Strategy by updating previous analyses that estimated and examined official development assistance targeted towards human resources for health.
We identify the pattern of garbage-coded deaths in the world and present the methods used to determine their redistribution to generate more plausible cause of death assignments.
In this independent prospective evaluation, we used both quantitative and qualitative data to assess the potential impact of the Brazil HealthRise programs on improving clinical and health outcomes for hypertension and diabetes patients in Teófilo Otoni and Vitoria da Conquista. We hypothesized that participation in the Brazil HealthRise program could lead to reduced biomarker readings and increase the proportion of individuals meeting treatment targets for both conditions.
We aimed to use comparable and standardised data sources to estimate human resources for health (HRH) densities globally, and to examine the relationship between a subset of HRH cadres and UHC effective coverage performance.
Our analysis presents the first ever estimates of entire distributions of stunting, wasting, and underweight for each of 204 countries and territories from 1990 to 2020 for children less than 5 years old by age group and sex.
The trends in vaccine confidence and resistance have implications for updating the social amplification of risk framework (SARF); in turn, SARF has practical implications for guiding efforts to alleviate vaccine hesitancy and to mitigate harms from intentional and unintentional vaccine scares.
We aimed to estimate the health outcomes and net cost of implementing postexposure prophylaxis (PEP) with monoclonal antibodies (mAbs) against household exposure to COVID-19.
In this study, we aimed to provide a novel approach to estimating past SARS-CoV-2 infections, combining data from reported cases, reported deaths, excess deaths attributable to COVID-19, hospitalizations, and seroprevalence surveys
In this study, we conducted a cost-effectiveness analysis of a Vitamin A Supplementation scale-up in Nigeria, Kenya, and Burkina Faso.
We examined the temporal patterns of the global, regional, and national burden of colorectal cancer and its risk factors in 204 countries and territories across the past three decades.
In this systematic analysis, we present the national and subnational estimates of the burden of disease in Iran using the Global Burden of Disease Study 2019.